Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report-Reference-Cited by-同舟云学术

Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report

Published:2021-07 Issue: Volume:151 Page:190-200
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Kim Hee J.^ORCID,Noh Woo C.,Nam Seok J.,Park Byeong-Woo,Lee Eun S.,Im Seock A.,Jung Yong S.,Yoon Jung H.,Kang Sung S.,Park Kyong H.,Lee Soo-Jung,Jeong Joon,Lee Min H.,Cho Se H.,Kim Sung Y.,Kim Hyun-Ah^ORCID,Han Se-Hwan,Han Wonshik,Hur Min H.^ORCID,Kim Seonok,Ahn Sei H.

Funder

Korea Health Industry Development Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference30 articles.

1. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study;Fidler;Lancet Oncol,2017

2. Subtype-dependent relationship between young age at diagnosis and breast cancer survival;Partridge;J Clin Oncol,2016

3. Tailoring adjuvant endocrine therapy for premenopausal breast cancer;Francis;N Engl J Med,2018

4. Adjuvant endocrine therapy in breast cancer: evolving paradigms in premenopausal women;Rossi;Curr Treat Options Oncol,2017

5. Improving adjuvant endocrine treatment tailoring in premenopausal women with hormone receptor-positive breast cancer;Lambertini;J Clin Oncol,2020

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer;JAMA Oncology;2024-08-15

2. Fertility Preservation for Young Women with Breast Cancer: Review and Perspective;Clinical and Experimental Obstetrics & Gynecology;2024-06-27

3. Empowerment-Led Guided Self-Help Intervention for Symptom Burden in Breast Cancer Women Treated With Ovarian Function Suppression: A Randomized Trial Protocol;World Journal of Oncology;2024-04

4. Selection of appropriate biomarkers to monitor effectiveness of ovarian function suppression in pre-menopausal patients with ER+ breast cancer;npj Breast Cancer;2024-01-19

5. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor–Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial;Journal of Clinical Oncology;2023-11-01